A public stock offering by Atara Biotherapeutics was set to close July 23, raising $150 million in gross proceeds for the company. The Thousand Oaks-based company offered 6.87 million shares of its common stock at its July 18 closing price of $15.28, as well as nearly 3 million pre-funded warrants for certain investors. Underwriters were…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
